A carregar...

Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia.

1. This study was designed to examine the effects of acipimox 250 mg three times daily and cholestyramine 4 g three times daily on plasma lipids and lipoproteins in 28 hypercholesterolaemic individuals in a prospective double-blind placebo controlled parallel group fashion. 2. Combined treatment wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Series, J J, Gaw, A, Kilday, C, Bedford, D K, Lorimer, A R, Packard, C J, Shepherd, J
Formato: Artigo
Idioma:Inglês
Publicado em: 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1368274/
https://ncbi.nlm.nih.gov/pubmed/2390432
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!